Cargando…
Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study
BACKGROUND: Little is known about risk factors associated with out-of-hospital outcomes in survivors of critical illness. We hypothesized that the presence of nucleated red blood cells in patients who survived critical care would be associated with adverse outcomes following hospital discharge. METH...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479031/ https://www.ncbi.nlm.nih.gov/pubmed/28633658 http://dx.doi.org/10.1186/s13054-017-1724-z |
_version_ | 1783245061197135872 |
---|---|
author | Purtle, Steven W. Horkan, Clare M. Moromizato, Takuhiro Gibbons, Fiona K. Christopher, Kenneth B. |
author_facet | Purtle, Steven W. Horkan, Clare M. Moromizato, Takuhiro Gibbons, Fiona K. Christopher, Kenneth B. |
author_sort | Purtle, Steven W. |
collection | PubMed |
description | BACKGROUND: Little is known about risk factors associated with out-of-hospital outcomes in survivors of critical illness. We hypothesized that the presence of nucleated red blood cells in patients who survived critical care would be associated with adverse outcomes following hospital discharge. METHODS: We performed a two-center observational cohort study of patients treated in medical and surgical intensive care units in Boston, Massachusetts. All data were obtained from the Research Patient Data Registry at Partners HealthCare. We studied 2878 patients, age ≥ 18 years, who received critical care between 2011 and 2015 and survived hospitalization. The exposure of interest was nucleated red blood cells occurring from 2 days prior to 7 days after critical care initiation. The primary outcome was mortality in the 90 days following hospital discharge. Secondary outcome was unplanned 30-day hospital readmission. Adjusted odds ratios were estimated by multivariable logistic regression models with inclusion of covariate terms thought to plausibly interact with both nucleated red blood cells and outcome. Adjustment included age, race (white versus nonwhite), gender, Deyo–Charlson Index, patient type (medical versus surgical), sepsis and acute organ failure. RESULTS: In patients who received critical care and survived hospitalization, the absolute risk of 90-day postdischarge mortality was 5.9%, 11.7%, 15.8% and 21.9% in patients with 0/μl, 1–100/μl, 101–200/μl and more than 200/μl nucleated red blood cells respectively. Nucleated red blood cells were a robust predictor of postdischarge mortality and remained so following multivariable adjustment. The fully adjusted odds of 90-day postdischarge mortality in patients with 1–100/μl, 101–200/μl and more than 200/μl nucleated red blood cells were 1.77 (95% CI, 1.23–2.54), 2.51 (95% CI, 1.36–4.62) and 3.72 (95% CI, 2.16–6.39) respectively, relative to patients without nucleated red blood cells. Further, the presence of nucleated red blood cells is a significant predictor of the odds of unplanned 30-day hospital readmission. CONCLUSION: In critically ill patients who survive hospitalization, the presence of nucleated red blood cells is a robust predictor of postdischarge mortality and unplanned hospital readmission. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1724-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5479031 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54790312017-06-23 Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study Purtle, Steven W. Horkan, Clare M. Moromizato, Takuhiro Gibbons, Fiona K. Christopher, Kenneth B. Crit Care Research BACKGROUND: Little is known about risk factors associated with out-of-hospital outcomes in survivors of critical illness. We hypothesized that the presence of nucleated red blood cells in patients who survived critical care would be associated with adverse outcomes following hospital discharge. METHODS: We performed a two-center observational cohort study of patients treated in medical and surgical intensive care units in Boston, Massachusetts. All data were obtained from the Research Patient Data Registry at Partners HealthCare. We studied 2878 patients, age ≥ 18 years, who received critical care between 2011 and 2015 and survived hospitalization. The exposure of interest was nucleated red blood cells occurring from 2 days prior to 7 days after critical care initiation. The primary outcome was mortality in the 90 days following hospital discharge. Secondary outcome was unplanned 30-day hospital readmission. Adjusted odds ratios were estimated by multivariable logistic regression models with inclusion of covariate terms thought to plausibly interact with both nucleated red blood cells and outcome. Adjustment included age, race (white versus nonwhite), gender, Deyo–Charlson Index, patient type (medical versus surgical), sepsis and acute organ failure. RESULTS: In patients who received critical care and survived hospitalization, the absolute risk of 90-day postdischarge mortality was 5.9%, 11.7%, 15.8% and 21.9% in patients with 0/μl, 1–100/μl, 101–200/μl and more than 200/μl nucleated red blood cells respectively. Nucleated red blood cells were a robust predictor of postdischarge mortality and remained so following multivariable adjustment. The fully adjusted odds of 90-day postdischarge mortality in patients with 1–100/μl, 101–200/μl and more than 200/μl nucleated red blood cells were 1.77 (95% CI, 1.23–2.54), 2.51 (95% CI, 1.36–4.62) and 3.72 (95% CI, 2.16–6.39) respectively, relative to patients without nucleated red blood cells. Further, the presence of nucleated red blood cells is a significant predictor of the odds of unplanned 30-day hospital readmission. CONCLUSION: In critically ill patients who survive hospitalization, the presence of nucleated red blood cells is a robust predictor of postdischarge mortality and unplanned hospital readmission. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1724-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-21 /pmc/articles/PMC5479031/ /pubmed/28633658 http://dx.doi.org/10.1186/s13054-017-1724-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Purtle, Steven W. Horkan, Clare M. Moromizato, Takuhiro Gibbons, Fiona K. Christopher, Kenneth B. Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study |
title | Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study |
title_full | Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study |
title_fullStr | Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study |
title_full_unstemmed | Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study |
title_short | Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study |
title_sort | nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479031/ https://www.ncbi.nlm.nih.gov/pubmed/28633658 http://dx.doi.org/10.1186/s13054-017-1724-z |
work_keys_str_mv | AT purtlestevenw nucleatedredbloodcellscriticalillnesssurvivorsandpostdischargeoutcomesacohortstudy AT horkanclarem nucleatedredbloodcellscriticalillnesssurvivorsandpostdischargeoutcomesacohortstudy AT moromizatotakuhiro nucleatedredbloodcellscriticalillnesssurvivorsandpostdischargeoutcomesacohortstudy AT gibbonsfionak nucleatedredbloodcellscriticalillnesssurvivorsandpostdischargeoutcomesacohortstudy AT christopherkennethb nucleatedredbloodcellscriticalillnesssurvivorsandpostdischargeoutcomesacohortstudy |